Oxygen Targets in Acute Heart Failure With Pulmonary Congestion
NCT05613218
Summary
This investigator-initiated, prospective, randomized, blinded, multi-center, controlled trial will investigate the effect of a restrictive vs. liberal oxygenation-strategy in patients hospitalized with acute heart failure with pulmonary congestion. Patients will be randomized 1:1 in the emergency department to either liberal or restrictive oxygenation after providing informed written consent. 1. Liberal oxygenation group = SpO2 target of 96%. 2. Restrictive oxygenation group = SpO2 target of 90%. The allocation will be concealed through the use of an oxygen-delivery robot, termed O2MATIC. The study will include 122 patients.
Eligibility
Inclusion Criteria: 1. Age ≥ 18 years 2. Acute (within minutes to days) onset or worsening of subjective dyspnea 3. Oxygen saturation \<92% (on arterial blood gas) or need of oxygen 4. At least one of the following clinical or radiological signs of congestion: 1\. Pulmonary rales 2. Chest X-ray or CT with pulmonary congestion 3. Lung ultrasound with multiple B-lines Exclusion Criteria: 1. More than 4 hours from hospital admission to randomization 2. Suspected infection or sepsis 3. Known severe pulmonary disease 4. Systolic blood pressure \<90 mmHg
Conditions4
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05613218